Verrica Pharmaceuticals Inc. (VRCA) has a market capitalization of $60.93M and trades at $5.72. The 52-week range is 3.28-9.821.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.4, Earnings Per Share (EPS) of $-1.68, annual revenue of $35.58M.
The stock has a beta of 1.43, operates in the Healthcare sector.
